1.585
Zentalis Pharmaceuticals Inc Aktie (ZNTL) Neueste Nachrichten
How to integrate Zentalis Pharmaceuticals Inc. into portfolio analysis toolsWeekly Gains Summary & AI Optimized Trade Strategies - Newser
Can a trend reversal in Zentalis Pharmaceuticals Inc. lead to recoveryMarket Volume Summary & Weekly High Conviction Ideas - Newser
What are the risks of holding Zentalis Pharmaceuticals Inc.Profit Target & Consistent Income Trade Recommendations - kangso.co.kr
Analyzing recovery setups for Zentalis Pharmaceuticals Inc. investorsJuly 2025 Analyst Calls & AI Powered Buy and Sell Recommendations - Newser
Zentalis Pharmaceuticals Inc. stock outlook for YEAR2025 Dividend Review & Free Real-Time Market Sentiment Alerts - Newser
Sentiment analysis tools applied to Zentalis Pharmaceuticals Inc.July 2025 News Drivers & Proven Capital Preservation Tips - Newser
Using economic indicators to assess Zentalis Pharmaceuticals Inc. potentialWeekly Investment Report & Fast Momentum Entry Tips - Newser
Price Clustering Detected in Zentalis Pharmaceuticals Inc. StockMarket Risk Analysis & Fast Entry Momentum Alerts - 선데이타임즈
Using flow based indicators on Zentalis Pharmaceuticals Inc.July 2025 Outlook & Daily Growth Stock Investment Tips - Newser
Has Zentalis Pharmaceuticals Inc. Stock Ever Crashed Historical Volatility ReviewTrend Reversal Watch with Entry Signals - Newser
Applying Wyckoff theory to Zentalis Pharmaceuticals Inc. stockHigh Win Rate Strategy with Stop Protection - Newser
Is Zentalis Pharmaceuticals Inc. stock a smart retirement pickROI Focused Stock Opportunities - mustnews.co.kr
Wells Fargo & Company Has Lowered Expectations for Zentalis Pharmaceuticals (NASDAQ:ZNTL) Stock Price - MarketBeat
Custom watchlist performance reports with Zentalis Pharmaceuticals Inc.Price Spike Prediction for Active Traders - Newser
Leerink Partnrs Has Pessimistic View of ZNTL Q3 Earnings - Defense World
Equities Analysts Offer Predictions for ZNTL Q3 Earnings - Defense World
When is the best time to exit Zentalis Pharmaceuticals Inc.Predictive AI Signals for Short-Term Trading - Newser
Watch for Trend Continuation in Zentalis Pharmaceuticals Inc. Next WeekTechnical Stock Breakout Predictions Signal Entry Points - beatles.ru
Zentalis price target lowered to $5 from $6 at Wells Fargo - MSN
Wall Street Zen Upgrades Zentalis Pharmaceuticals (NASDAQ:ZNTL) to Hold - Defense World
Why Zentalis Pharmaceuticals Inc. stock attracts strong analyst attentionFree Trend Analysis for Safer Trades - Newser
ZNTL: Wells Fargo Adjusts Price Target, Maintains Rating | ZNTL Stock News - GuruFocus
Zentalis Pharmaceuticals: Hold Rating Amid Delayed Catalysts and Market Skepticism - TipRanks
Strategic Advancements and Promising Clinical Data Support Buy Rating for Zentalis Pharmaceuticals - TipRanks
Zentalis Pharmaceuticals Inc reports results for the quarter ended June 30Earnings Summary - TradingView
A Quick Look at Today's Ratings for Zentalis Pharmaceuticals(ZNTL.US), With a Forecast Between $5 to $10 - 富途牛牛
Zentalis Pharmaceuticals Reports Improved Financial Results - TipRanks
Zentalis (ZNTL) Q2 Loss Narrows 70% - The Motley Fool
Zentalis (ZNTL) Q2 Loss Narrows 70% - AOL.com
Zentalis Pharmaceuticals: Navigating the Crossroads of Innovation and Financial Prudence - AInvest
Zentalis Pharmaceuticals Reports Q2 2025 Financial Results - TipRanks
Zentalis Pharma's Q2 operating expenses down - TradingView
Zentalis Pharmaceuticals Reports Second Quarter 2025 Financial Results and Operational Progress - GlobeNewswire
Zentalis Advances Revolutionary Ovarian Cancer Drug with $303M War Chest, FDA Fast-Track Potential - Stock Titan
Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) Given Average Recommendation of “Moderate Buy” by Brokerages - Defense World
51,061 Shares in Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) Bought by Universal Beteiligungs und Servicegesellschaft mbH - Defense World
Real time social sentiment graph for Zentalis Pharmaceuticals Inc.Free Portfolio Diversification Stock Ideas - Newser
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):